000 | 01345 a2200349 4500 | ||
---|---|---|---|
005 | 20250518054122.0 | ||
264 | 0 | _c20210106 | |
008 | 202101s 0 0 eng d | ||
022 | _a1537-6591 | ||
024 | 7 |
_a10.1093/cid/ciz784 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aMiyahara, Sachiko | |
245 | 0 | 0 |
_aApplying a Risk-benefit Analysis to Outcomes in Tuberculosis Clinical Trials. _h[electronic resource] |
260 |
_bClinical infectious diseases : an official publication of the Infectious Diseases Society of America _c02 2020 |
||
300 |
_a698-703 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural | ||
650 | 0 | 4 |
_aAntitubercular Agents _xtherapeutic use |
650 | 0 | 4 | _aClinical Trials as Topic |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aIsoniazid |
650 | 0 | 4 | _aRisk Assessment |
650 | 0 | 4 |
_aTuberculosis _xdrug therapy |
700 | 1 | _aRamchandani, Ritesh | |
700 | 1 | _aKim, Soyeon | |
700 | 1 | _aEvans, Scott R | |
700 | 1 | _aGupta, Amita | |
700 | 1 | _aSwindells, Susan | |
700 | 1 | _aChaisson, Richard E | |
700 | 1 | _aMontepiedra, Grace | |
773 | 0 |
_tClinical infectious diseases : an official publication of the Infectious Diseases Society of America _gvol. 70 _gno. 4 _gp. 698-703 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1093/cid/ciz784 _zAvailable from publisher's website |
999 |
_c30006990 _d30006990 |